Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cytokinetics Insider Sold Shares Worth $357,400, According to a Recent SEC Filing

Cytokinetics Insider Sold Shares Worth $357,400, According to a Recent SEC Filing

MT newswireMT newswire2026/09/01 21:01
05:01 PM EDT, 09/01/2026 (MT Newswires) -- B Lynne Parshall, Director, on September 01, 2026, sold 5,000 shares in Cytokinetics (CYTK) for $357,400. Following the Form 4 filing with the SEC, Parshall has control over a total of 10,784 common shares of the company, with 10,784 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198326000091/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!